CN107236703A - 一种饲养层细胞、培养方法及应用 - Google Patents
一种饲养层细胞、培养方法及应用 Download PDFInfo
- Publication number
- CN107236703A CN107236703A CN201710380719.6A CN201710380719A CN107236703A CN 107236703 A CN107236703 A CN 107236703A CN 201710380719 A CN201710380719 A CN 201710380719A CN 107236703 A CN107236703 A CN 107236703A
- Authority
- CN
- China
- Prior art keywords
- chicken
- cell
- feeder cells
- culture
- feeder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 13
- 210000004027 cell Anatomy 0.000 claims abstract description 64
- 241000287828 Gallus gallus Species 0.000 claims abstract description 27
- 210000000130 stem cell Anatomy 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 11
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 10
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims description 8
- 239000006285 cell suspension Substances 0.000 claims description 7
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 6
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 6
- 210000004602 germ cell Anatomy 0.000 claims description 6
- JZDHUJAFXGNDSB-UHFFFAOYSA-N glutamylalanine Chemical compound OC(=O)C(C)NC(=O)C(N)CCC(O)=O JZDHUJAFXGNDSB-UHFFFAOYSA-N 0.000 claims description 6
- 239000003102 growth factor Substances 0.000 claims description 6
- 239000002609 medium Substances 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 108010016626 Dipeptides Proteins 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 5
- 238000000338 in vitro Methods 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 210000000988 bone and bone Anatomy 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 230000009977 dual effect Effects 0.000 claims description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 4
- 229960004857 mitomycin Drugs 0.000 claims description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- 210000002798 bone marrow cell Anatomy 0.000 claims description 3
- 230000029087 digestion Effects 0.000 claims description 3
- 210000002257 embryonic structure Anatomy 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000002777 nucleoside Substances 0.000 claims description 3
- 125000003835 nucleoside group Chemical group 0.000 claims description 3
- 210000002303 tibia Anatomy 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- 210000000689 upper leg Anatomy 0.000 claims description 3
- 230000002792 vascular Effects 0.000 claims description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 210000002950 fibroblast Anatomy 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 3
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 3
- 230000002411 adverse Effects 0.000 abstract description 2
- 230000003321 amplification Effects 0.000 abstract description 2
- 238000007796 conventional method Methods 0.000 abstract description 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 2
- 238000011017 operating method Methods 0.000 abstract description 2
- 239000001963 growth medium Substances 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 9
- 230000012010 growth Effects 0.000 description 8
- 238000010166 immunofluorescence Methods 0.000 description 6
- 238000003822 preparative gas chromatography Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 3
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000004072 osteoblast differentiation Effects 0.000 description 3
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 101150090523 DAZL gene Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 230000011759 adipose tissue development Effects 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- 101100498453 Caenorhabditis elegans daz-1 gene Proteins 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001517368 Coelogyne Species 0.000 description 1
- 102100033672 Deleted in azoospermia-like Human genes 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000871280 Homo sapiens Deleted in azoospermia-like Proteins 0.000 description 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
- 102100025304 Integrin beta-1 Human genes 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000004940 costimulation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710380719.6A CN107236703B (zh) | 2017-05-25 | 2017-05-25 | 一种饲养层细胞、培养方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710380719.6A CN107236703B (zh) | 2017-05-25 | 2017-05-25 | 一种饲养层细胞、培养方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107236703A true CN107236703A (zh) | 2017-10-10 |
CN107236703B CN107236703B (zh) | 2021-06-01 |
Family
ID=59985632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710380719.6A Active CN107236703B (zh) | 2017-05-25 | 2017-05-25 | 一种饲养层细胞、培养方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107236703B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109221894A (zh) * | 2018-10-19 | 2019-01-18 | 佛山科学技术学院 | 一种菜籽粕化学脱毒装置 |
CN114807115A (zh) * | 2022-05-18 | 2022-07-29 | 上海珈凯生物科技有限公司 | 一种衰老细胞的构建方法及评价抗衰老功效的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102161980A (zh) * | 2011-02-12 | 2011-08-24 | 浙江大学 | 用人间充质干细胞为滋养层培养诱导多能干细胞的方法 |
CN104911144A (zh) * | 2015-05-21 | 2015-09-16 | 佛山科学技术学院 | 一种鸡生殖新月来源PGCs的分离培养方法 |
-
2017
- 2017-05-25 CN CN201710380719.6A patent/CN107236703B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102161980A (zh) * | 2011-02-12 | 2011-08-24 | 浙江大学 | 用人间充质干细胞为滋养层培养诱导多能干细胞的方法 |
CN104911144A (zh) * | 2015-05-21 | 2015-09-16 | 佛山科学技术学院 | 一种鸡生殖新月来源PGCs的分离培养方法 |
Non-Patent Citations (2)
Title |
---|
ZOHREH MAKOOLATI等: "proliferation in culture of primordial germ cells derived from embryonic stem cell: induction by retinoic acid", 《BIOSCI. REP.》 * |
张秋婷等: "饲养层及细胞因子对鸡PGCs体外培养的影响", 《生物技术通报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109221894A (zh) * | 2018-10-19 | 2019-01-18 | 佛山科学技术学院 | 一种菜籽粕化学脱毒装置 |
CN114807115A (zh) * | 2022-05-18 | 2022-07-29 | 上海珈凯生物科技有限公司 | 一种衰老细胞的构建方法及评价抗衰老功效的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107236703B (zh) | 2021-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101412985B (zh) | 用于骨髓间充质干细胞体外培养和扩增的无血清培养基 | |
CN104263697B (zh) | 一种诱导培养基及诱导人脂肪间充质干细胞生成胰岛素分泌细胞的方法 | |
CN101374942A (zh) | 干细胞及胚胎来源的心肌细胞及推定的心肌细胞的纯化方法 | |
CN106062179A (zh) | 无血清培养基 | |
CN105779395A (zh) | 一种永生化的犬脂肪间充质干细胞系及其构建方法 | |
CN103667349B (zh) | 一种高效获取猪诱导性多能干细胞的方法 | |
CN104946590B (zh) | 成人骨髓中Muse细胞诱导为神经前体细胞的方法 | |
CN103966159B (zh) | 人胎盘亚全能干细胞及其干细胞库构建方法 | |
CN102933704A (zh) | 软骨祖细胞、用于细胞衍生的方案和其用途 | |
CN103087977A (zh) | 一种体外高效扩增动物细胞的培养液及其用途 | |
CN102344906A (zh) | 一种毛囊干细胞的分离培养方法 | |
CN108795850A (zh) | 一种精原干细胞体外无饲养层长期培养方法 | |
CN105132360A (zh) | 一种诱导胎盘间充质干细胞分化为胰岛样细胞的方法 | |
CN105779377A (zh) | 一种分离鸡胚血来源的原始生殖干细胞的方法 | |
CN1884494B (zh) | 诱导人胚胎干细胞向肝脏细胞分化的方法及其专用培养基 | |
CN106434542A (zh) | 一种增强脂肪干细胞增殖与移植后存活能力的方法 | |
KR100569168B1 (ko) | 조류 정원줄기세포의 배양방법 및 이에 의해 수득한 조류정원줄기세포 | |
CN102286532A (zh) | 一种获得诱导性多能干细胞的方法 | |
CN107236703A (zh) | 一种饲养层细胞、培养方法及应用 | |
CN100540659C (zh) | 一种培养小鼠胚胎干细胞的方法及其专用培养基 | |
CN108753710A (zh) | 一种无血清完全培养基及其应用 | |
CN102154195B (zh) | 一种山羊雄性生殖干细胞的体外分离及培养方法 | |
CN107164325B (zh) | MSCs来源的少突胶质细胞的制备方法及试剂盒 | |
CN105368773A (zh) | 一种人皮肤干细胞体外分化单倍体生殖细胞的方法 | |
CN106318979A (zh) | 诱导间充质干细胞转分化为皮肤干细胞的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Shucan Inventor after: Chen Zhisheng Inventor after: Li Dongsheng Inventor after: Zhang Xiaofang Inventor after: Zheng Guichun Inventor before: Chen Zhisheng Inventor before: Zhao Meican Inventor before: Li Dongsheng Inventor before: Zhang Xiaofang Inventor before: Zheng Guichun |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220621 Address after: 528000 2F, No. 26-4, Zone C, Southwest Park, Sanshui Industrial Park, Sanshui District, Foshan City, Guangdong Province Patentee after: Guangdong zhengdakang Biotechnology Co.,Ltd. Address before: 528000 Foshan Institute of Science and Technology, No. 18 Jiangwan Road, Chancheng District, Foshan City, Guangdong Province Patentee before: FOSHAN University |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20171010 Assignee: Guangdong Yaoda Financial Leasing Co.,Ltd. Assignor: Guangdong zhengdakang Biotechnology Co.,Ltd. Contract record no.: X2022980014825 Denomination of invention: Feeder layer cell, culture method and application Granted publication date: 20210601 License type: Exclusive License Record date: 20220913 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Feeder layer cell, culture method and application Effective date of registration: 20220915 Granted publication date: 20210601 Pledgee: Guangdong Yaoda Financial Leasing Co.,Ltd. Pledgor: Guangdong zhengdakang Biotechnology Co.,Ltd. Registration number: Y2022980015290 |